Dysregulated MAPK signaling pathway in acute myeloid leukemia with RUNX1 mutations.
Mingmin HeYongqin JiaYan WangXiongwei CaiPublished in: Expert review of hematology (2022)
RUNX1 could modulate MAPK pathway, which may provide a potential therapeutic target for AML patients with RUNX1 mutations.